Intron retention regulates STAT2 function and associates with immunotherapy response in lung cancer
Ryan P. Englander, Mattia Brugiolo, Maëva Devoucoux, Te-Chia Wu, Mitch Kostich, Nathan K. Leclair, Isha A. Walawalkar, Hyeon Gu Kang 等 18 位
The Jackson Laboratory for Genomic Medicine UConn Health Nationwide Children's Hospital Abigail Wexner Research Institute
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for treating various diseases, including lung cancer. However, the molecular determinants of variable patient outcomes remain unclear. Using long-read RNA sequencing, we mapped the landscape of alternative RNA splicing in human primary lung adenocarcinomas. We identified more than 149,000 full-length messenger RNA (mRNA) isoforms, more than half of which were unannotated and many that occurred in immune-related genes, particularly within the type I interferon response pathway. We functionally characterized retained introns in the STAT2 gene that produced altered protein isoforms that regulated immune signaling and interferon responses and correlated with patient survival after anti–programmed death-ligand 1 (PD-L1) immunotherapy. These findings position alternative splicing as a regulator of tumor immune responses and reveal intron retention in STAT2 as an interferon regulatory axis that correlates with PD-L1 checkpoint inhibitor response.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学RNA Research and Splicing
Cancer Immunotherapy and Biomarkers · RNA regulation and disease